Company

Pacira BioSciences, Inc.

Headquarters: Parsippany, NJ, United States

Employees: 697

CEO: Mr. David M. Stack

NASDAQ: PCRX +1.70%

Market Cap

$1.59 Billion

USD as of Jan. 1, 2024

Market Cap History

Pacira BioSciences, Inc. market capitalization over time

Evolution of Pacira BioSciences, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Pacira BioSciences, Inc.

Detailed Description

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Pacira BioSciences, Inc. has the following listings and related stock indices.


Stock: NASDAQ: PCRX wb_incandescent

Stock: FSX: 82P wb_incandescent

Details

Headquarters:

5 Sylvan Way

Suite 300

Parsippany, NJ 07054

United States

Phone: 973 254 3560